enGene Inc. Warrants

NASDAQ: ENGNW · Real-Time Price · USD
0.65
0.00 (0.00%)
At close: Aug 18, 2025, 9:30 AM
0.65
0.00%
After-hours: Aug 18, 2025, 04:00 PM EDT

enGene Warrants Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 175K n/a n/a
Gross Profit
n/a -175K n/a n/a
Operating Income
62.3M -26.06M -19.43M -15.87M
Interest Income
10.41M 1.12M 129K 25K
Pretax Income
55.16M -99.9M -24.44M -225K
Net Income
55.14M -99.92M -24.46M -23.44M
Selling & General & Admin
23.98M 9.43M 3.26M 3.15M
Research & Development
38.31M 16.46M 15.47M 12.46M
Other Expenses
n/a n/a -393K n/a
Operating Expenses
62.3M 25.89M 19.43M 15.87M
Interest Expense
2.8M 4.95M 1.42M 5.02M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
62.3M 26.06M 19.43M 15.87M
Income Tax Expense
-19K 17K 22K 4.9M
Shares Outstanding (Basic)
44.64M 23.56M 15.81M 15.81M
Shares Outstanding (Diluted)
44.64M 23.56M 15.81M 15.81M
EPS (Basic)
1.24 -4.24 -1.55 -1.48
EPS (Diluted)
1.24 -4.24 -1.55 -1.48
EBITDA
62.3M -94.77M -19.45M -15.7M
EBIT
57.96M -94.95M 30.73K -225K
Depreciation & Amortization
323K 175K 238K 272K